Health care workers are at risk for occupational transmission of hepatitis C virus (HCV) through needlestick accidents [1, 2] . Unfortunately, neither neutralizing antibody nor a vaccine for preventing HCV transmission has been developed [3] [4] [5] . Two of our h~alth care workers recently acquired acute hepatitis C through needlestick accidents. We discuss a treatment strategy with IFN that prevented both individuals fromdeveloping chronic hepatitis C.
Case Reports
Case 1. The patient was an 83-year-old woman with chronic HCV infection, and the health care worker was a 44-year-old female nurse (figure 1A). The nurse had had normal liver function and was seronegative for antibodies to hepatitis B virus (HBV) and HCV before the needlestick accident, but 1.5 months after the accident, she was found to have an elevated alanine aminotransferase (ALT) level. At 1.8 months, HCV RNA was detected in her serum, and at 2.2 months, antibodies to HCV were detected. Since her ALT levels fluctuated and her serum was persistently positive for HCV RNA, therapy with SC natural IFN-a-2a (OIF R , Otsuka Pharmaceutical Co., Ltd., Tokyo) was started at 3.8 months (dosage, 10 megaunits for 6 consecutive weeks, given daily for 2 weeks and then three times a week for 4 weeks; total dose, 260 megaunits). About 10 months after completing treatment, her ALT levels had normalized, and her serum was negative for HCV RNA.
Case 2. The patient was an 88-year-old man with chronic HCV infection, and the health care worker was a 27-year-old male surgeon who had had normal liver function and was seronegative for antibodies to HBV and HCV before the needlestick accident (figure 1B). At 1.5 months after the injury, he was found to have an elevated serum ALT level; at 1.6 months, HCV RNA was detected in his serum; and at 3 months, antibodies to HCV were detected. Since his ALT levels fluctuated and his serum was persistently positive for HCV RNA, treatment with iv natural IFN-,B (Feron, Daiichi Pharmaceutical Co., Ltd., Tokyo) was started at 2.7 months (dosage, 6 megaunits for 8 consecutive weeks, given 6 days a week for 8 weeks; total dose, 288 megaunits). His ALT levels normalized, and his serum was found to be negative for HCV RNA 7.5 months after completion of therapy.
In both cases, eight HCV clones from both the patient and the health care worker formed a monophyletic cluster; these clones were genetically closely related (figure 2).
Methods
Antibody to HCV was assayed with use of ABBOTT HCV PHA 2nd Generation (DAINABOT Co., Ltd., Tokyo). HCV RNA was detected by using the Amplicor Monitor (Nippon Roche Co., Ltd., Tokyo) [6] . 5'-TATTCCATGGTGGGGAACTGG-3' and 5'-AGTCCT-GTTGATRTGCCARCTGCC-3'. Eight HCY clones from each HCY-infected patient and health care worker were sequenced and analyzed as described by Suzuki et al. [7] .
Discussion
We used molecular evolutionary analysis to prove that these two health care workers acquired HCY through accidental needlesticks. It is believed that the development of a neutralizing antibody or a vaccine to prevent HCY infection may be difficult [3, 4] and that prophylactic administration of gamma globulin immediately after a needlestick injury is of doubtful efficacy [5] . Nakano et al. [8] administered IFN prophylactically at a dosage of 5 megaunits per day for 4 days immediately after an accidental needlestick [8] , but this prophylaxis did not prevent HCY infection from developing. Thus, a method for preventing infection after exposure to HCY has not been established. On the other hand, even small doses of IFN are effective in treating acute posttransfusion hepatitis C [9] .
In the present study, IFN (~300 megaunits) was given to the health care workers after the onset of acute hepatitis to prevent them from developing chronic hepatitis. More than 6 months after completing the treatment, both individuals had normal ALT levels, and both were seronegative for HCY RNA. Because the findings in two cases are not enough to confirm the efficacy of this treatment approach, further casecontrolled studies are needed. Our results support the hy- pothesis that administering low-dose IFN immediately after ALT levels are found to be elevated might be more beneficial and cost effective than administering IFN immediately after an accidental needlestick. Figure 1 . Clinical course of two health care workers (A, a 44-yearold female nurse; E, a 27-year-old male surgeon) with acute hepatitis C caused by accidental needlesticks. In both cases, findings on examination of a needle biopsy specimen from the liver were consistent with acute hepatitis. ALT = alanine aminotransferase; HCV = hepatitis C virus; IFN = interferon.
